May 1, 2012 (Miami, Florida) — For patients with brain metastases from non–small cell lung cancer (NSCLC), the risk for leukoencephalopathy was much lower if they were treated with stereotactic ...
Stereotactic radiosurgery (SRS) and stereotactic ablative body radiotherapy (SABR) are advancing precision oncology by delivering highly accurate, high-dose radiation that achieves strong local ...
Dr. Sujoy Fernandes News Editor Profile at TheHealthSite.com including Facebook and twitter profile. Checkout Latest Post by Dr. Sujoy Fernandes ...
Craniopharyngiomas account for 2–5% of all primary brain tumors and 5–10% of pediatric brain tumors. Despite their benign histology, their location near the hypothalamus, pituitary gland, and optic ...
Patritumab deruxtecan (HER3-DXd) in active brain metastases from metastatic breast and non-small cell lung cancers, and leptomeningeal disease from advanced solid tumors: The TUXEDO-3 phase II trial.
Preoperative stereotactic radiotherapy (SRT) was just as safe as postoperative SRT for patients with resectable brain metastases. More patients treated with preoperative SRT completed both radiation ...
People who experience side effects from cranial radiation therapy may recover full neurocognitive function within months. (HealthDay News) — Many patients with brain metastases who experience initial ...
Craniopharyngiomas account for 2–5% of all primary brain tumors and 5–10% of pediatric brain tumors. Despite their benign histology, their location near the hypothalamus, pituitary gland, and optic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results